{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:13:08Z","timestamp":1787026388754,"version":"build-2736575974"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is a heterogeneous disorder, affecting around 10% of women of reproductive age, with infertility, depression or anxiety, obesity, insulin resistance and type 2 diabetes as risk factors. The cause of PCOS is not known but there is a predisposition to developing PCOS in adult life that arises during fetal or perinatal life. PCOS also has a genetic predisposition and a number of genetic loci associated with PCOS have been identified. These loci contain 25 candidate genes which are currently being studied to define the syndrome. Although the name PCOS suggests a syndrome of the ovary, PCOS has also been associated with the central nervous system and other organ systems in the body due to the wide variety of symptoms it presents.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Here, we examined the expression patterns of PCOS candidate genes in gonadal (ovary and testis), metabolic (heart, liver and kidney) and brain (brain and cerebellum) tissues during the first half of human fetal development and postnatally until adulthood using public RNA sequencing data. This study is an initial step for more comprehensive and translational studies to define PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We found that the genes were dynamically expressed in the fetal tissues studied. Some genes were significantly expressed in gonadal tissues, whilst others were expressed in metabolic or brain tissues at different time points prenatally and\/or postnatally.\n                      <jats:italic>HMGA2<\/jats:italic>\n                      ,\n                      <jats:italic>FBN3<\/jats:italic>\n                      and\n                      <jats:italic>TOX3<\/jats:italic>\n                      were highly expressed during the early stages of fetal development in all tissues but least during adulthood. Interestingly, correlation between expression of\n                      <jats:italic>HMGA2\/YAP1<\/jats:italic>\n                      and\n                      <jats:italic>RAD50\/YAP1<\/jats:italic>\n                      were significant in at least 5 of the 7 fetal tissues studied. Notably,\n                      <jats:italic>DENND1A, THADA, MAPRE1, RAB5B, ARL14EP, KRR1, NEIL2<\/jats:italic>\n                      and\n                      <jats:italic>RAD50<\/jats:italic>\n                      were dynamically expressed in all postnatal tissues studied.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      These findings suggest that these genes have tissue- or development-specific roles in multiple organs, possibly resulting in the various symptoms associated with PCOS. Thus the fetal origin of a predisposition to PCOS in adulthood could arise\n                      <jats:italic>via<\/jats:italic>\n                      the effects of PCOS candidate genes in the development of multiple organs.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2023.1149473","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T07:52:09Z","timestamp":1683532329000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Genes in loci genetically associated with polycystic ovary syndrome are dynamically expressed in human fetal gonadal, metabolic and brain tissues"],"prefix":"10.3389","volume":"14","author":[{"given":"Rafiatu","family":"Azumah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Hummitzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond J.","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/jwh.2014.5000","article-title":"Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study","volume":"24","author":"Joham","year":"2015","journal-title":"J Women's Health"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/j.fertnstert.2011.03.001","article-title":"Extent of metabolic risk in adolescent girls with features of polycystic ovary syndrome","volume":"95","author":"Hart","year":"2011","journal-title":"Fertil Steril"},{"key":"B3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2004.05.001","article-title":"Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome","volume":"18","author":"Hart","year":"2004","journal-title":"Best Pract Res Clin Obstetr Gynaecol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.metabol.2017.09.016","article-title":"Polycystic ovarian syndrome (PCOS): long-term metabolic consequences","volume":"86","author":"Anagnostis","year":"2018","journal-title":"Metabolism"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2012.02.004","article-title":"Lean mass and insulin resistance in women with polycystic ovary syndrome","volume":"61","author":"Comerford","year":"2012","journal-title":"Metabolism"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2018.11.002","article-title":"Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics","volume":"92","author":"Glueck","year":"2019","journal-title":"Metabolism"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2016.01.006","article-title":"Metabolic profile in women with polycystic ovary syndrome across adult life","volume":"65","author":"Echibur\u00fa","year":"2016","journal-title":"Metabolism"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2014.05.004","article-title":"Clustering of metabolic and cardiovascular risk factors in the polycystic ovary syndrome: a principal component analysis","volume":"63","author":"Stuckey","year":"2014","journal-title":"Metabolism"},{"key":"B10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2147\/NSS.S127475","article-title":"Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies","volume":"10","author":"Fernandez","year":"2018","journal-title":"Nat Sci Sleep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3390\/biomedicines10061291","article-title":"Hepatic mitochondrial dysfunction and risk of liver disease in an ovine model of \u2018PCOS males","volume":"10","author":"Siemienowicz","year":"2022","journal-title":"Biomedicines"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0831-9","article-title":"Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects","volume":"50","author":"Baillargeon","year":"2007","journal-title":"Diabetologia"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-2190","article-title":"Metabolic phenotype in the brothers of women with polycystic ovary syndrome","volume":"31","author":"Sam","year":"2008","journal-title":"Diabetes Care"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.01981.x","article-title":"Insulin resistance and endothelial dysfunction in the brothers of Indian subcontinent Asian women with polycystic ovaries","volume":"60","author":"Kaushal","year":"2004","journal-title":"Clin Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0255","article-title":"Pituitary and testicular function in sons of women with polycystic ovary syndrome from infancy to adulthood","volume":"93","author":"Recabarren","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1530\/EC-17-0218","article-title":"Reproductive and metabolic features during puberty in sons of women with polycystic ovary syndrome","volume":"6","author":"Crisosto","year":"2017","journal-title":"Endocrine Connections"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229351","article-title":"Could perturbed fetal development of the ovary contribute to the development of polycystic ovary syndrome in later life","volume":"15","author":"Hartanti","year":"2020","journal-title":"PloS One"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.762177","article-title":"Analysis of upstream regulators, networks, and pathways associated with the expression patterns of polycystic ovary syndrome candidate genes during fetal ovary development","volume":"12","author":"Azumah","year":"2022","journal-title":"Front Genet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/biolre\/ioaa119","article-title":"Analysis of expression of candidate genes for polycystic ovary syndrome in adult and fetal human and fetal bovine ovaries","volume":"103","author":"Liu","year":"2020","journal-title":"Biol Reprod"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1338-5","article-title":"Gene expression across mammalian organ development","volume":"571","author":"Cardoso-Moreira","year":"2019","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-24277-4","article-title":"Package \u2018ggplot2\u2019","volume":"2","author":"Wickham","year":"2016","journal-title":"Create Elegant Data Visualisations Using Grammar Graphics Version"},{"key":"B22","doi-asserted-by":"publisher","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.3390\/jcm8101606","article-title":"The genetics of polycystic ovary syndrome: an overview of candidate gene systematic reviews and genome-wide association studies","volume":"8","author":"Hiam","year":"2019","journal-title":"J Clin Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1101\/gad.236745.113","article-title":"The Rad50 hook domain regulates DNA damage signaling and tumorigenesis","volume":"28","author":"Roset","year":"2014","journal-title":"Genes Dev"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00412-015-0535-8","article-title":"Functions of the MRE11 complex in the development and maintenance of oocytes","volume":"125","author":"Inagaki","year":"2016","journal-title":"Chromosoma"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.787733","article-title":"Thada is dispensable for female fertility in mice","volume":"13","author":"Han","year":"2022","journal-title":"Front Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2020.06.023","article-title":"Meta-analysis of gene expression profiles of lean and obese PCOS to identify differentially regulated pathways and risk of comorbidities","volume":"18","author":"Idicula-Thomas","year":"2020","journal-title":"Comput Struct Biotechnol J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"10762","DOI":"10.1038\/ncomms10762","article-title":"Corrigendum: genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations","volume":"7","author":"Hayes","year":"2016","journal-title":"Nat Commun"},{"key":"B29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbagrm.2009.11.013","article-title":"In vivo Modulation of HMGA2 expression","volume":"1799","author":"Ashar","year":"2010","journal-title":"Biochim Biophys Acta (BBA)-Gene Regul Mechanisms"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/74207","article-title":"In vivo Modulation of hmgic reduces obesity","volume":"24","author":"Anand","year":"2000","journal-title":"Nat Genet"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205501","article-title":"HMGA1 and HMGA2 protein expression in mouse spermatogenesis","volume":"21","author":"Chieffi","year":"2002","journal-title":"Oncogene"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.09.017","article-title":"Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf expression","volume":"135","author":"Nishino","year":"2008","journal-title":"Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/genes12020269","article-title":"HMGA2 as a critical regulator in cancer development","volume":"12","author":"Mansoori","year":"2021","journal-title":"Genes"},{"key":"B34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/15384047.2020.1832429","article-title":"HMGA2 promotes breast cancer metastasis by modulating hippo-YAP signaling pathway","volume":"22","author":"Xu","year":"2021","journal-title":"Cancer Biol Ther"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1650","article-title":"Granulosa cell survival and proliferation are altered in polycystic ovary syndrome","volume":"93","author":"Das","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00544","article-title":"The HMGA2-IMP2 pathway promotes granulosa cell proliferation in polycystic ovary syndrome","volume":"104","author":"Li","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0729","article-title":"Abnormal preantral folliculogenesis in polycystic ovaries is associated with increased granulosa cell division","volume":"92","author":"Stubbs","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B38","doi-asserted-by":"publisher","first-page":"812","DOI":"10.6026\/97320630015812","article-title":"Genotype based risk predictors for polycystic ovary syndrome in Western Saudi Arabia","volume":"15","author":"Bakhashab","year":"2019","journal-title":"Bioinformation"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2016.20","article-title":"Oocyte-expressed yes-associated protein is a key activator of the early zygotic genome in mouse","volume":"26","author":"Yu","year":"2016","journal-title":"Cell Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1242\/dev.102376","article-title":"The hippo pathway effectors TAZ and YAP in development, homeostasis and disease","volume":"141","author":"Varelas","year":"2014","journal-title":"Development"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.06.007","article-title":"The hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating yorkie, the drosophila homolog of YAP","volume":"122","author":"Huang","year":"2005","journal-title":"Cell"},{"key":"B42","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/cr.2015.98","article-title":"A miR-130a-YAP positive feedback loop promotes organ size and tumorigenesis","volume":"25","author":"Shen","year":"2015","journal-title":"Cell Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2014.10","article-title":"VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex","volume":"24","author":"Zhang","year":"2014","journal-title":"Cell Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/molehr\/gax046","article-title":"The polycystic ovary syndrome-associated gene Yap1 is regulated by gonadotropins and sex steroid hormones in hyperandrogenism-induced oligo-ovulation in mouse","volume":"23","author":"Ji","year":"2017","journal-title":"MHR: Basic Sci Reprod Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005768","article-title":"Promoter methylation of yes-associated protein (YAP1) gene in polycystic ovary syndrome","volume":"96","author":"Jiang","year":"2017","journal-title":"Medicine"},{"key":"B46","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr Rev"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2016.11.008","article-title":"Oocyte competence in women with polycystic ovary syndrome","volume":"28","author":"Palomba","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"B48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/B978-0-12-813209-8.00004-2","article-title":"Development of the mammalian ovary and follicles","author":"Hummitzsch","year":"2019","journal-title":"Ovary: Elsevier"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deaa144","article-title":"Associations between polycystic ovary syndrome and adverse obstetric and neonatal outcomes: a population study of 9.1 million births","volume":"35","author":"Mills","year":"2020","journal-title":"Hum Reprod"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119995","article-title":"Insulin receptor signaling in the GnRH neuron plays a role in the abnormal GnRH pulsatility of obese female mice","volume":"10","author":"DiVall","year":"2015","journal-title":"PloS One"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deaa125","article-title":"Transmission of polycystic ovary syndrome susceptibility single-nucleotide polymorphisms and their association with phenotype changes in offspring","volume":"35","author":"Li","year":"2020","journal-title":"Hum Reprod"},{"key":"B52","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1080\/09513590.2022.2121386","article-title":"Daughters of polycystic ovary syndrome pregnancies and androgen levels in puberty: a meta-analysis","volume":"38","author":"Valsamakis","year":"2022","journal-title":"Gynecol Endocrinol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.5.8387","article-title":"Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome","volume":"87","author":"Legro","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B54","doi-asserted-by":"publisher","first-page":"bqab225","DOI":"10.1210\/endocr\/bqab225","article-title":"Developmental programming: prenatal testosterone excess on liver and muscle coding and noncoding RNA in female sheep","volume":"163","author":"Saadat","year":"2022","journal-title":"Endocrinology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024877","article-title":"The in utero programming effect of increased maternal androgens and a direct fetal intervention on liver and metabolic function in adult sheep","volume":"6","author":"Hogg","year":"2011","journal-title":"PloS One"},{"key":"B56","doi-asserted-by":"publisher","first-page":"105829","DOI":"10.1016\/j.jsbmb.2021.105829","article-title":"Long-term androgen excess induces insulin resistance and non-alcoholic fatty liver disease in PCOS-like rats","volume":"208","author":"Cui","year":"2021","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02600-1","article-title":"Glucocorticoid signaling and lipid metabolism disturbances in the liver of rats treated with 5\u03b1-dihydrotestosterone in an animal model of polycystic ovary syndrome","volume":"72","author":"Vojnovi\u0107 Milutinovi\u0107","year":"2021","journal-title":"Endocrine"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-021-00835-8","article-title":"Colocalization analysis of polycystic ovary syndrome to identify potential disease-mediating genes and proteins","volume":"29","author":"Censin","year":"2021","journal-title":"Eur J Hum Genet"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-00169","article-title":"Co-Localization of polycystic ovary syndrome candidate gene products in theca cells suggests novel signaling pathways","volume":"3","author":"Kulkarni","year":"2019","journal-title":"J Endocrine Society"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007813","article-title":"Large-Scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria","volume":"14","author":"Day","year":"2018","journal-title":"PloS Genet"},{"key":"B61","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/REP-19-0197","article-title":"Mechanisms of intergenerational transmission of polycystic ovary syndrome","volume":"159","author":"Dumesic","year":"2020","journal-title":"Reproduction"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1080\/17446651.2019.1576522","article-title":"Hyperandrogenic origins of polycystic ovary syndrome\u2013implications for pathophysiology and therapy","volume":"14","author":"Abbott","year":"2019","journal-title":"Expert Rev Endocrinol Metab"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3780","article-title":"Perspectives in polycystic ovary syndrome: from hair to eternity","volume":"101","author":"Dunaif","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168870","article-title":"Phenotype and tissue expression as a function of genetic risk in polycystic ovary syndrome","volume":"12","author":"Pau","year":"2017","journal-title":"PloS One"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00274","article-title":"PCOS-GWAS susceptibility variants in THADA, INSR, TOX3, and DENND1A are associated with metabolic syndrome or insulin resistance in women with PCOS","volume":"11","author":"Tian","year":"2020","journal-title":"Front Endocrinol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2014.12.004","article-title":"Functional genomics of PCOS: from GWAS to molecular mechanisms","volume":"26","author":"McAllister","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"B67","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ecl.2020.10.006","article-title":"Genetics of polycystic ovary syndrome: what is new","volume":"50","author":"Welt","year":"2021","journal-title":"Endocrinol Metab Clinics"},{"key":"B68","volume-title":"International evidence-based guideline for the assessment and management of polycystic ovary syndrome 2018","author":"Teede","year":"2018"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1149473\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T07:52:16Z","timestamp":1683532336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1149473\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,8]]},"references-count":68,"alternative-id":["10.3389\/fendo.2023.1149473"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1149473","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,8]]},"article-number":"1149473"}}